These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37384284)

  • 21. Predicting Speech Intelligibility Decline in Amyotrophic Lateral Sclerosis Based on the Deterioration of Individual Speech Subsystems.
    Rong P; Yunusova Y; Wang J; Zinman L; Pattee GL; Berry JD; Perry B; Green JR
    PLoS One; 2016; 11(5):e0154971. PubMed ID: 27148967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vocal tract steadiness: a measure of phonatory and upper airway motor control during phonation in dysarthria.
    Zwirner P; Barnes GJ
    J Speech Hear Res; 1992 Aug; 35(4):761-8. PubMed ID: 1405531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acoustic, perceptual and clinical correlates of speech and voice in isolated dystonia: Preliminary findings.
    Cuartero MC; Bertrand R; Rauzy S; Véron-Delor L; Atkinson-Clement C; Grabli D; Vidailhet M; Pinto S
    Int J Lang Commun Disord; 2021 Nov; 56(6):1204-1217. PubMed ID: 34383363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Auditory-Perceptual Features of Speech in Children and Adults With Down Syndrome: A Speech Profile Analysis.
    Kent RD; Eichhorn J; Wilson EM; Suk Y; Bolt DM; Vorperian HK
    J Speech Lang Hear Res; 2021 Apr; 64(4):1157-1175. PubMed ID: 33789057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain volumetric correlates of dysarthria in multiple sclerosis.
    Rusz J; Vaneckova M; Benova B; Tykalova T; Novotny M; Ruzickova H; Uher T; Andelova M; Novotna K; Friedova L; Motyl J; Kucerova K; Krasensky J; Horakova D
    Brain Lang; 2019 Jul; 194():58-64. PubMed ID: 31102976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acoustic analysis of voice in amyotrophic lateral sclerosis: a longitudinal case study.
    Ramig LO; Scherer RC; Klasner ER; Titze IR; Horii Y
    J Speech Hear Disord; 1990 Feb; 55(1):2-14. PubMed ID: 2299836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acoustic characteristics in relation to intelligibility reduction in noise for speakers with Parkinson's disease.
    Chiu Y; Neel A; Loux T
    Clin Linguist Phon; 2021 Mar; 35(3):222-236. PubMed ID: 32539544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A preliminary study of factors influencing perception of articulatory rate in Parkinson disease.
    Tjaden K
    J Speech Lang Hear Res; 2000 Aug; 43(4):997-1010. PubMed ID: 11386485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards an automatic evaluation of the dysarthria level of patients with Parkinson's disease.
    Vásquez-Correa JC; Orozco-Arroyave JR; Bocklet T; Nöth E
    J Commun Disord; 2018; 76():21-36. PubMed ID: 30149241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A quantitative method for the assessment of dysarthrophonia in myasthenia gravis.
    Konstantopoulos K; Christou YP; Vogazianos P; Zamba-Papanicolaou E; Kleopa KA
    J Neurol Sci; 2017 Jun; 377():42-46. PubMed ID: 28477705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Efficacy Study of Voice Quality Using Cepstral Analyses of Phonation in Parkinson's Disease before and after SPEAK-OUT!®.
    Boutsen FR; Park E; Dvorak JD
    Folia Phoniatr Logop; 2023; 75(1):35-42. PubMed ID: 35817007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterizing intonation deficit in motor speech disorders: an autosegmental-metrical analysis of spontaneous speech in hypokinetic dysarthria, ataxic dysarthria, and foreign accent syndrome.
    Lowit A; Kuschmann A
    J Speech Lang Hear Res; 2012 Oct; 55(5):1472-84. PubMed ID: 23033442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do Phonatory Aerodynamic and Acoustic Measures in Connected Speech Differ Between Vocally Healthy Adults and Patients Diagnosed with Muscle Tension Dysphonia?
    Belsky MA; Rothenberger SD; Gillespie AI; Gartner-Schmidt JL
    J Voice; 2021 Jul; 35(4):663.e1-663.e7. PubMed ID: 31932188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Average Spectral (LTAS) Measures of Dysarthria and Their Relationship to Perceived Severity.
    Tjaden K; Sussman JE; Liu G; Wilding G
    J Med Speech Lang Pathol; 2010 Dec; 18(4):125-132. PubMed ID: 29422763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guidelines for Speech Recording and Acoustic Analyses in Dysarthrias of Movement Disorders.
    Rusz J; Tykalova T; Ramig LO; Tripoliti E
    Mov Disord; 2021 Apr; 36(4):803-814. PubMed ID: 33373483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Speech discrimination impairments as a marker of disease severity in multiple sclerosis.
    Iva P; Fielding J; Clough M; White O; Noffs G; Godic B; Martin R; van der Walt A; Rajan R
    Mult Scler Relat Disord; 2021 Jan; 47():102608. PubMed ID: 33189020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Speech and pause characteristics associated with voluntary rate reduction in Parkinson's disease and Multiple Sclerosis.
    Tjaden K; Wilding G
    J Commun Disord; 2011; 44(6):655-65. PubMed ID: 21767851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acoustic and Perceptual Analyses of Adductor Spasmodic Dysphonia in Mandarin-speaking Chinese.
    Chen Z; Li J; Ren Q; Ge P
    J Voice; 2019 May; 33(3):333-339. PubMed ID: 29449062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progression of dysprosody in Parkinson's disease over time--a longitudinal study.
    Skodda S; Rinsche H; Schlegel U
    Mov Disord; 2009 Apr; 24(5):716-22. PubMed ID: 19117364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vowel acoustics in Parkinson's disease and multiple sclerosis: comparison of clear, loud, and slow speaking conditions.
    Tjaden K; Lam J; Wilding G
    J Speech Lang Hear Res; 2013 Oct; 56(5):1485-502. PubMed ID: 23838989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.